A Study of Ribavirin in the Treatment of Patients With AIDS and AIDS-Related Problems

NCT00001015 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

96

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Ribavirin

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)